Global Oncology Forecasting & Analytics Director

Johnson & Johnson Innovation; Raritan (NJ); On-site; USD 122,000 - 213,000; Full time

Job summary

Johnson & Johnson is seeking an Associate Director, Global Oncology Forecasting, Analytics, and Market Research in Raritan, NJ. The candidate will develop/maintain forecast models, deliver global forecasts, and lead primary market research to inform long-range planning and strategic decisions.

The role requires a strong blend of data analysis, strategic storytelling, and cross-functional collaboration to translate customer learnings into actionable recommendations for the Global Oncology

Qualifications

• A minimum of a Bachelor's degree and 8 years or advanced degree and 5 years of progressive business experience in Forecasting, Market Research, Quantitative Sciences, Business Analytics, Competitive Intelligence, Business Development, or Marketing
• Forecasting experience within the pharmaceutical industry

Responsibilities

• Develop/maintain/update forecast models to inform long-range financial planning and governance milestone decisions.
• Lead and deliver Market Research via primary and secondary methods; translate insights into actionable recommendations.
• Collaborate with Global Oncology teams and cross-functional partners to optimize commercial development strategies

Skills

Data Analysis

Strategic Communication

Strategic Thinking

Collaboration

Influencing

Project Management

Operational Excellence

Critical Thinking

Learning Agility

Navigating Ambiguity

Education

Bachelor's degree

Advanced degree

Job description

Johnson & Johnson is seeking an Associate Director, Global Oncology Forecasting, Analytics, and Market Research in Raritan, NJ. The candidate will develop/maintain forecast models, deliver global forecasts, and lead primary market research to inform long-range planning and strategic decisions.

The role requires a strong blend of data analysis, strategic storytelling, and cross-functional collaboration to translate customer learnings into actionable recommendations for the Global Oncology